RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.

In the second part of his Pharma Commerce video interview, Mark Lee, MarqVision’s founder and CEO, explains how wide regional ...

President Trump wrote to major drug companies, informing them that they had to comply with his “Most Favored Nation” order.

Pfizer faces challenges from pricing pressures, a 2026 patent cliff, and weak R&D momentum. Click here to find out why I rate ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

With Trump's backing, the pharma industry is leaning into the idea of more "direct-to-consumer" sales. But experts say the ...

An experimental Pfizer sickle cell treatment failed to meet the main goal in a late-stage trial for patients aged 16 and ...

The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...

Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table?

Biosimilar Market was estimated at USD 31.20 Bn in 2024 and is expected to grow at a CAGR of 17.4% from 2025 to 2032, reaching nearly USD 112.59 Bn by 2032. Biosimilars are redefining access to ...

Rising demand for personal care and cosmetic products is a major factor driving the growth of personal care contract manufacturing. This trend is primarily supported by higher per capita income ...